Blog

Notes and updates. For the reference material, see the guides.

• Tesamorelin vs. Sermorelin: Abdominal Visceral Adiposity vs. General Anti-Aging Tesamorelin vs sermorelin: the Egrifta phase 3 visceral fat data, sermorelin's Geref history and withdrawal, licensed doses, risks and reconstitution.
• Reconstituting GHRPs and GHRHs: Maintaining Peptide Fragility and Longevity How to reconstitute ipamorelin, sermorelin, CJC-1295 and GHRPs: which reconstitution water to use, 2 mg and 5 mg vial maths, syringe tables and storage.
• GHRP Comparison: GHRP-2, GHRP-6, and Hexarelin Signaling Differences GHRP-2, GHRP-6 and hexarelin compared: ghrelin receptor signalling, the GHRP-6 hunger effect, cortisol and prolactin release, hexarelin desensitisation.
• CJC-1295 (DAC vs. No-DAC) and Ipamorelin: Synergistic GH Pulsing CJC-1295 with DAC vs no-DAC (Mod GRF 1-29) and ipamorelin: receptors, half-lives, the human trial data, FDA compounding status and reconstitution maths.